Watchlist
AI Drug Discovery
Pure-play AI-driven drug-discovery platforms - generative biology, computational chemistry, antibody design, and protein-structure prediction applied to therapeutic pipelines. Companies where AI is the differentiator, not a buzzword bolted onto a traditional biotech. Seed members are 2026's 4 cleanest public listings on this thesis; the basket will grow as new IPOs land and Insitro-class private names go public.
source: editorial 2026-05-18
Hypothetical· equal-weight buy at inception, mark-to-market today
May 18 → Aug 14 · 4/4 picks · equal-weightAntibody discovery
1 pick- #4ABCL$11.38last
Computational chemistry
1 pick- #3SDGR$17.59last
Generative biology
1 pick- #1GENB$15.64last
Phenomics platform
1 pick- #2RXRX$3.16last
Frequently asked questions
- What stocks are in the AI Drug Discovery watchlist?
- The AI Drug Discovery watchlist tracks 4 tickers on QuantAbundancia: ABCL, SDGR, GENB, RXRX.
- What is the AI Drug Discovery watchlist?
- Pure-play AI-driven drug-discovery platforms - generative biology, computational chemistry, antibody design, and protein-structure prediction applied to therapeutic pipelines. Companies where AI is the differentiator, not a buzzword bolted onto a traditional biotech. Seed members are 2026's 4 cleanest public listings on this thesis; the basket will grow as new IPOs land and Insitro-class private names go public.